9th Annual Mutational Scanning Symposium in Melbourne
Poster # 096
Thursday, March 26, 2026 5:30 - 7:30pm Abstract Poster
Kristin Kohler, Ashley P.L. Marsh, Colin Young, Jamie Weyandt, Sarah Dugger, Daniel Zimmerman, Magan Trottier, Steven Harrison, Marcy E. Richardson. Clinical impact of integrating BRCA2 MAVE data for variant reclassification: A real‑world evaluation.
Session # 098
Thursday, March 26, 2026 12:45 - 1:00pm Abstract
Daniel Zimmerman, Sarah Dugger, Ashley Marsh, Dean Hoffer, Ana Silverstein, John Ranola, Heather Zimmermann, Sean Korpela, Marcy Richardson, Katie Yergert, Tina Pesaran. MAVE progress report, how Ambry Genetics validates and deploys high-throughput functional assays
Session # 099
Wednesday, March 25, 2026 4:30 - 4:45pm Abstract
Ashley P.L. Marsh, Shelby L. Hemker, Kristin Kohler, Daniel Zimmerman, Felicia P. Hernandez, Jacob O. Kitzman, Marcy E. Richardson. Clinical translation of a MUTYH MAVE into a diagnostic laboratory workflow enables largescale VUS resolution
Session # 097
Wednesday, March 25, 2026 2:15 - 2:30pm Abstract
Melissa A. Gilbert, Monica Bowen, Tristan J. Hayek, Marcy E. Richardson, Laura Conlin, Ramakrishnan Rajagopalan, Erica Smith, Ashley Marsh, Jill Murrell, Nancy B. Spinner. Clinical utility of Multiplexed Assays of Variant Effects (MAVEs) in a pediatric cohort